FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts

AIM: To evaluate the efficacy and safety of the FOLFIRI regimen in patients with metastatic pancreatic adenocarcinoma (PAC) after the failure of gemcitabine and platinum salts. METHODS: All consecutive patients with histologically confirmed, metastatic PAC and World Health Organization performance s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Neuzillet, Cindy, Hentic, Olivia, Rousseau, Benoît, Rebours, Vinciane, Bengrine-Lefèvre, Léïla, Bonnetain, Franck, Lévy, Philippe, Raymond, Eric, Ruszniewski, Philippe, Louvet, Christophe, Hammel, Pascal
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Co., Limited 2012
Matèries:
Brief Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3435778/
https://ncbi.nlm.nih.gov/pubmed/22969226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i33.4533
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars